Package 63539-051-30

{"route": ["ORAL"], "spl_id": "0e981f94-fca4-43e8-b88a-4b4b844f8edc", "openfda": {"unii": ["02WK9U5NZC"], "rxcui": ["2099954", "2099956", "2591510", "2591512"], "spl_set_id": ["13839d4f-6acf-4ffb-a128-79df59319273"], "manufacturer_name": ["U.S. Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (63539-051-30)  / 30 CAPSULE in 1 BOTTLE", "package_ndc": "63539-051-30", "marketing_end_date": "20260630", "marketing_start_date": "20230621"}], "brand_name": "Talzenna", "product_id": "63539-051_0e981f94-fca4-43e8-b88a-4b4b844f8edc", "dosage_form": "CAPSULE", "pharm_class": ["Poly(ADP-Ribose) Polymerase Inhibitor [EPC]", "Poly(ADP-Ribose) Polymerase Inhibitors [MoA]"], "product_ndc": "63539-051", "generic_name": "talazoparib", "labeler_name": "U.S. Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Talzenna", "active_ingredients": [{"name": "TALAZOPARIB TOSYLATE", "strength": ".5 mg/1"}], "application_number": "NDA211651", "marketing_category": "NDA", "marketing_end_date": "20260630", "marketing_start_date": "20230621"}